Kraematon Investment Advisors, Inc Wave Life Sciences Ltd. Transaction History
Kraematon Investment Advisors, Inc
- $93.8 Million
- Q1 2024
A detailed history of Kraematon Investment Advisors, Inc transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Kraematon Investment Advisors, Inc holds 22,000 shares of WVE stock, worth $117,040. This represents 0.14% of its overall portfolio holdings.
Number of Shares
22,000
Previous 47,000
53.19%
Holding current value
$117,040
Previous $237,000
43.04%
% of portfolio
0.14%
Previous 0.27%
Shares
2 transactions
Others Institutions Holding WVE
# of Institutions
132Shares Held
71.8MCall Options Held
86.1KPut Options Held
20.1K-
Lee Ainslie Maverick Capital LTD | Dallas, Tx7.69MShares$40.9 Million0.94% of portfolio
-
M28 Capital Management LP Stamford, CT7MShares$37.2 Million40.53% of portfolio
-
Black Rock Inc. New York, NY6.38MShares$33.9 Million0.0% of portfolio
-
683 Capital Management, LLC New York, NY5.35MShares$28.5 Million2.81% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.2MShares$27.7 Million0.06% of portfolio
About Wave Life Sciences Ltd.
- Ticker WVE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,820,096
- Market Cap $462M
- Description
- Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...